Skip to main content
Clinical Trials/CTRI/2019/01/017359
CTRI/2019/01/017359
Not yet recruiting
Phase 3

A Comparative Study to Evaluate Effectiveness of Pathya Counsellingin Management of Amavata (Rheumatoid Arthritis)

Chaudhary Brahm Prakash Ayurved Charak Sansthan0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Chaudhary Brahm Prakash Ayurved Charak Sansthan
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Chaudhary Brahm Prakash Ayurved Charak Sansthan

Eligibility Criteria

Inclusion Criteria

  • Patients having the clinical features of Amavata as described in Madhav Nidana
  • Patients fulfilling the 2010 ACR\-EULAR criteria for Rheumatoid arthritis
  • Patients who are only on commonly prescribed Ayurvedic treatment of Amavata
  • Patients not following any dietary restrictions from past 6 months
  • Age 21 to 60 years
  • Sex both sexes
  • Patients suffering from disease for less than 3yrs
  • Patients who are ready to give consent for trial
  • Patients with firm home address and contact no which is readily accessible during course of trial

Exclusion Criteria

  • Concomitant any other treatment (DMARDs glucocorticoids etc) other than commonly prescribed Ayurvedic treatment of Amavata Patients with crippling bone deformities Seriously ill and moribund patients
  • Abnormal renal or hepatic functions malignancy hypertension cardiovascular disorder HIV\-AIDS etc
  • Patients planning to conceive in near future (during course of trial)
  • Pregnant and lactating mothers
  • Any major psychiatric illness
  • Any other pre\-existing illness that will require surgery during course of trial
  • Patients with any other concomitant Arthropathy like Ankylosing Spondylosis Osteomyelitis Gouty Arthritis Neoplasm of spine Fractures etc

Outcomes

Primary Outcomes

Not specified

Similar Trials